BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 18554679)

  • 41. Self-delivering nanoemulsions for dual fluorine-19 MRI and fluorescence detection.
    Janjic JM; Srinivas M; Kadayakkara DK; Ahrens ET
    J Am Chem Soc; 2008 Mar; 130(9):2832-41. PubMed ID: 18266363
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Design and optimization of a new self-nanoemulsifying drug delivery system.
    Wang L; Dong J; Chen J; Eastoe J; Li X
    J Colloid Interface Sci; 2009 Feb; 330(2):443-8. PubMed ID: 19038395
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lipid nanoemulsions for anti-cancer drug therapy.
    Souto EB; Nayak AP; Murthy RS
    Pharmazie; 2011 Jul; 66(7):473-8. PubMed ID: 21812320
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nanoscale double emulsions stabilized by single-component block copolypeptides.
    Hanson JA; Chang CB; Graves SM; Li Z; Mason TG; Deming TJ
    Nature; 2008 Sep; 455(7209):85-8. PubMed ID: 18769436
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Redox-Responsive Gene Delivery from Perfluorocarbon Nanoemulsions through Cleavable Poly(2-oxazoline) Surfactants.
    Estabrook DA; Day RA; Sletten EM
    Angew Chem Int Ed Engl; 2021 Aug; 60(32):17362-17367. PubMed ID: 33930255
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Design of the interface of edible nanoemulsions to modulate the bioaccessibility of neuroprotective antioxidants.
    Plaza-Oliver M; Baranda JF; Rodríguez Robledo V; Castro-Vázquez L; Gonzalez-Fuentes J; Marcos P; Lozano MV; Santander-Ortega MJ; Arroyo-Jimenez MM
    Int J Pharm; 2015 Jul; 490(1-2):209-18. PubMed ID: 25997659
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nanoemulsions prepared by a two-step low-energy process.
    Wang L; Mutch KJ; Eastoe J; Heenan RK; Dong J
    Langmuir; 2008 Jun; 24(12):6092-9. PubMed ID: 18489188
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nanobiohybrids as delivery vehicles for camptothecin.
    Tyner KM; Schiffman SR; Giannelis EP
    J Control Release; 2004 Mar; 95(3):501-14. PubMed ID: 15023461
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Studies on the preparation of camptothecin niosomes].
    Luan LB; Zhu JB; Yu WP; Wei KB
    Yao Xue Xue Bao; 2002 Jan; 37(1):59-62. PubMed ID: 12579902
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Formulation development and optimization of a novel Cremophore EL-based nanoemulsion using ultrasound cavitation.
    Tang SY; Manickam S; Wei TK; Nashiru B
    Ultrason Sonochem; 2012 Mar; 19(2):330-45. PubMed ID: 21835676
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combined application of camptothecin and the guanylate cyclase activator YC-1: Impact on cell death and apoptosis-related proteins in ovarian carcinoma cell lines.
    Lee SJ; Kim YJ; Lee CS; Bae J
    Chem Biol Interact; 2009 Oct; 181(2):185-92. PubMed ID: 19481069
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of oil type on nanoemulsion formation and Ostwald ripening stability.
    Wooster TJ; Golding M; Sanguansri P
    Langmuir; 2008 Nov; 24(22):12758-65. PubMed ID: 18850732
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of topical nanoemulsions containing the isoflavone genistein.
    Silva AP; Nunes BR; De Oliveira MC; Koester LS; Mayorga P; Bassani VL; Teixeira HF
    Pharmazie; 2009 Jan; 64(1):32-5. PubMed ID: 19216228
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Physiochemical and cytotoxicity study of TPGS stabilized nanoemulsion designed by ultrasonication method.
    Kaur K; Kumar R; Arpita ; Goel S; Uppal S; Bhatia A; Mehta SK
    Ultrason Sonochem; 2017 Jan; 34():173-182. PubMed ID: 27773233
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Self-nanoemulsifying drug delivery systems (SNEDDS) for oral delivery of protein drugs: I. Formulation development.
    Rao SV; Shao J
    Int J Pharm; 2008 Oct; 362(1-2):2-9. PubMed ID: 18650038
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical developments of chemotherapeutic nanomedicines: polymers and liposomes for delivery of camptothecins and platinum (II) drugs.
    Kieler-Ferguson HM; Fréchet JM; Szoka FC
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013; 5(2):130-8. PubMed ID: 23335566
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protein-olive oil-in-water nanoemulsions as encapsulation materials for curcumin acting as anticancer agent towards MDA-MB-231 cells.
    Bharmoria P; Bisht M; Gomes MC; Martins M; Neves MC; Mano JF; Bdikin I; Coutinho JAP; Ventura SPM
    Sci Rep; 2021 Apr; 11(1):9099. PubMed ID: 33907277
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A novel procedure for preparation of submicron liposomes-lyophilization of oil-in-water emulsions.
    Wang T; Wang N; Jin X; Zhang K; Li T
    J Liposome Res; 2009; 19(3):231-40. PubMed ID: 19263267
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Polymeric perfluorocarbon nanoemulsions are ultrasound-activated wireless drug infusion catheters.
    Zhong Q; Yoon BC; Aryal M; Wang JB; Ilovitsh T; Baikoghli MA; Hosseini-Nassab N; Karthik A; Cheng RH; Ferrara KW; Airan RD
    Biomaterials; 2019 Jun; 206():73-86. PubMed ID: 30953907
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A novel non-toxic camptothecin formulation for cancer chemotherapy.
    Berrada M; Serreqi A; Dabbarh F; Owusu A; Gupta A; Lehnert S
    Biomaterials; 2005 May; 26(14):2115-20. PubMed ID: 15576186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.